These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Obsessive-compulsive disorder: historic review and update on the use of novel antidepressants. Winstead DK; Hurst CO; Salins C; Goodman A; Tynes LL Psychiatr Med; 1990; 8(4):49-58. PubMed ID: 2087570 [No Abstract] [Full Text] [Related]
43. [Antidepressive agents in the treatment of obsessive-compulsive disorder]. Hansen ES; Bolwig TG Ugeskr Laeger; 1997 Jan; 159(2):183-4. PubMed ID: 9012092 [No Abstract] [Full Text] [Related]
44. Are placebo-controlled trials still important for obsessive compulsive disorder? Fineberg NA; Hawley CJ; Gale TM Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):413-22. PubMed ID: 16413647 [TBL] [Abstract][Full Text] [Related]
45. Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder. Oztürk M; Coskun M J Clin Psychopharmacol; 2009 Dec; 29(6):607-9. PubMed ID: 19910732 [No Abstract] [Full Text] [Related]
46. Treatment of some cases in child psychiatry with incisive neuroleptic drugs. Stárková L; Mrna B Acta Univ Palacki Olomuc Fac Med; 1989; 123():287-91. PubMed ID: 2576177 [TBL] [Abstract][Full Text] [Related]
47. On the selection and use of atypical antipsychotics in the management of nonpsychotic mood and anxiety disorders. Blier P J Psychiatry Neurosci; 2005 Jul; 30(4):304. PubMed ID: 16049572 [No Abstract] [Full Text] [Related]
48. Breakthrough in psychiatric care. Pharmacological treatment of obsessive-compulsive disorders with implications for nursing care. Giger JN; Davidhizar R; Poole VL; Malone SB J Pract Nurs; 2000 Mar; 50(1):23-8; quiz 29-31. PubMed ID: 11951236 [No Abstract] [Full Text] [Related]
49. Antipsychotic augmentation in the treatment of obsessive-compulsive disorder. Thamby A; Jaisoorya TS Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S51-S57. PubMed ID: 30745677 [TBL] [Abstract][Full Text] [Related]
50. Beyond depression. What do those "mood drugs" really do? Lemonick MD Time; 1999 May; 153(19):74. PubMed ID: 10387666 [No Abstract] [Full Text] [Related]
51. [A new therapeutic principle in mania]. Gross H; Kaltenbäck E Wien Med Wochenschr; 1966 Dec; 116(50):1102-6. PubMed ID: 5340056 [No Abstract] [Full Text] [Related]
55. Publication bias and meta-analysis. Gilbody S; House A Br J Psychiatry; 1995 Aug; 167(2):266. PubMed ID: 7582683 [No Abstract] [Full Text] [Related]
56. Neuroti excoriations--a quantitative approach to the effect of treatment. Savin JA Br J Clin Pract; 1970 Oct; 24(10):451-4. PubMed ID: 5492889 [No Abstract] [Full Text] [Related]
57. Clinical effectiveness of antidepressants and antipsychotics in chronic benign pain. Zitman FG; Linssen AC; Edelbroek PM; Van Kempen GM Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():377A-378A. PubMed ID: 1354044 [No Abstract] [Full Text] [Related]
58. [The importance of inter-rater reliability in psychopharmacological trials]. Berendsen S; Van HL; van Tricht MJ; Verdegaal LMA; Blankers M; de Haan L Tijdschr Psychiatr; 2021; 63(9):638-643. PubMed ID: 34647301 [TBL] [Abstract][Full Text] [Related]
59. Issues in drug management. Part I. Antidepressants and chronic nonmalignant pain: a review. Getto CJ; Sorkness CA; Howell T J Pain Symptom Manage; 1987; 2(1):9-18. PubMed ID: 2881969 [No Abstract] [Full Text] [Related]
60. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Koran LM; Hanna GL; Hollander E; Nestadt G; Simpson HB; Am J Psychiatry; 2007 Jul; 164(7 Suppl):5-53. PubMed ID: 17849776 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]